6 completed, 4 terminated. 10 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 6, Terminated 4 |
Follow paricalcitol: new trials by email Literature Review of paricalcitol trials Research Report on paricalcitol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy 5-FU, Leucovorin, Liposomal Irinotecan - Pancreatic Cancer, Pancreas Cancer | Phase 1 | Completed | Washington University School of Medicine | 20 | 2019-07-11 | 2022-10-05 |
| Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer Gemcitabine, Nab-paclitaxel, Paricalcitol - Pancreatic Cancer | Phase 1 | Terminated | Dana-Farber Cancer Institute | 36 | 2018-12-05 | 2025-03-21 |
| A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer Paricalcitol - Pancreatic Cancer | Phase 1 | Terminated | Abramson Cancer Center at Penn Medicine | 3 | 2017-09-28 | 2022-03-31 |
| Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery Gemcitabine Hydrochloride, Laboratory Biomarker Analysis, Nab-paclitaxel - Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7 | Phase 1 | Completed | M.D. Anderson Cancer Center | 9 | 2017-02-20 | 2023-02-09 |
| A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer Paricalcitol, Abraxane, Gemcitabine - Adenocarcinoma of the Pancreas | Phase 1 | Completed | Abramson Cancer Center at Penn Medicine | 15 | 2014-01-01 | 2025-07-25 |
| Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions Paricalcitol Capsules, 4 mcg - Healthy | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 69 | 2010-11-01 | 2014-12-23 |
| Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery paricalcitol, radiation therapy, laboratory biomarker analysis - Mucinous Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer | Phase 1 | Terminated | Wake Forest University Health Sciences | 2 | 2010-08-01 | 2018-07-02 |
| Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer docetaxel, ixabepilone, paclitaxel - Breast Cancer | Phase 1 | Completed | Wake Forest University Health Sciences | 24 | 2008-03-01 | 2017-05-30 |
| Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders paricalcitol, zoledronic acid - Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 | Terminated | Roswell Park Cancer Institute | 7 | 2005-08-01 | 2013-02-01 |
| Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer gemcitabine hydrochloride, paricalcitol - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Roswell Park Cancer Institute | 34 | 2004-08-01 | 2014-12-09 |
Pancreatic Neoplasms (3) · Breast Neoplasms (1) · Multiple Myeloma (1) · Neoplasms, Plasma Cell (1) · Rectal Neoplasms (1)
Abramson Cancer Center at Penn Medicine (2) · Roswell Park Cancer Institute (2) · Wake Forest University Health Sciences (2) · Dana-Farber Cancer Institute (1) · Dr. Reddy's Laboratories Limited (1) · M.D. Anderson Cancer Center (1) · Washington University School of Medicine (1)
United States (9) · India (1)
Peter O'Dwyer, MD (2) · Asher A. Chanan-Khan, MD (1) · Brandon G Smaglo, MD (1) · Dr. Pankaj Kumar Jha, MD (1) · George Yacoub, MD (1) · Julia A. Lawrence (1) · Kian-Huat Lim, M.D, Ph.D. (1) · Kimberly Perez, MD (1) · Renuka Iyer, MD (1) · Susan A. Melin, MD (1)
P30CA012197 (1)